Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study.

Kalinowski M, Dressler M, König A, El-Sheik M, Rinke A, Höffken H, Gress TM, Arnold R, Klose KJ, Wagner HJ.

Digestion. 2009;79(3):137-42. doi: 10.1159/000209849. Epub 2009 Mar 23.

PMID:
19307736
2.

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center.

Arslan N, Emi M, Alagöz E, Ustünsöz B, Oysul K, Arpaci F, Uğurel S, Beyzadeoğlu M, Ozgüven MA.

Vojnosanit Pregl. 2011 Apr;68(4):341-8.

PMID:
21627019
3.

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.

King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, Morris DL.

Cancer. 2008 Sep 1;113(5):921-9. doi: 10.1002/cncr.23685.

4.

Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.

Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, Schmidt GP, Ashoori N, Reiser MF, Jakobs TF.

Cardiovasc Intervent Radiol. 2012 Apr;35(2):334-42. doi: 10.1007/s00270-011-0248-1. Epub 2011 Aug 17.

PMID:
21847708
5.

Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.

Wong CY, Savin M, Sherpa KM, Qing F, Campbell J, Gates VL, Lewandowski RJ, Cheng V, Thie J, Fink-Bennett D, Nagle C, Salem R.

Cancer Biother Radiopharm. 2006 Aug;21(4):305-13.

PMID:
16999596
6.

Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.

Peker A, Çiçek O, Soydal Ç, Küçük NÖ, Bilgiç S.

Diagn Interv Radiol. 2015 Jan-Feb;21(1):54-9. doi: 10.5152/dir.2014.14036.

7.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB 3rd, Salem R.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):887-94. doi: 10.1016/j.ijrobp.2011.07.041. Epub 2011 Dec 2.

8.

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.

Cao CQ, Yan TD, Bester L, Liauw W, Morris DL.

Br J Surg. 2010 Apr;97(4):537-43. doi: 10.1002/bjs.6931.

PMID:
20205229
9.

90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.

Fidelman N, Kerlan RK Jr, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP.

J Gastrointest Cancer. 2014 Jun;45(2):168-80. doi: 10.1007/s12029-013-9566-7.

PMID:
24448917
10.

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R.

Am J Clin Oncol. 2008 Jun;31(3):271-9. doi: 10.1097/COC.0b013e31815e4557.

PMID:
18525307
11.

A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.

Mancini R, Carpanese L, Sciuto R, Pizzi G, Golfieri R, Giampalma L, Cappelli A, Galaverni MC, Blotta A, Fiore F, Izzo F, Lastoria S, Mastro A, Di Marzo M, Cagol PP, Gasparini D, Geatti O, Bacchetti S, Pasqual E, Zeuli M, Paoletti G, Garufi C, Cosimelli M; Italian Society of Locoregional Therapies in Oncology..

In Vivo. 2006 Nov-Dec;20(6A):711-4.

12.

Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.

Wong CY, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM, Lewandowski RJ, Nagle C, Salem R.

J Vasc Interv Radiol. 2005 Aug;16(8):1101-6.

PMID:
16105922
13.

Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.

Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B.

J Nucl Med. 1994 Oct;35(10):1637-44.

14.

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.

Smits ML, van den Hoven AF, Rosenbaum CE, Zonnenberg BA, Lam MG, Nijsen JF, Koopman M, van den Bosch MA.

PLoS One. 2013 Jul 24;8(7):e69448. doi: 10.1371/journal.pone.0069448. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/559e04cc-b09c-4b5c-9405-56837f6d5627.

15.

Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.

Burgmans MC, Kao YH, Irani FG, Dames EL, Teo TK, Goh AS, Chow PK, Tay KH, Lo RH.

J Vasc Interv Radiol. 2012 Oct;23(10):1294-301. doi: 10.1016/j.jvir.2012.07.009. Epub 2012 Aug 24.

PMID:
22922039
16.

Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.

Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY.

J Vasc Interv Radiol. 2012 Mar;23(3):323-30.e1. doi: 10.1016/j.jvir.2011.11.007. Epub 2012 Jan 25.

PMID:
22277275
17.

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

Rhee TK, Lewandowski RJ, Liu DM, Mulcahy MF, Takahashi G, Hansen PD, Benson AB 3rd, Kennedy AS, Omary RA, Salem R.

Ann Surg. 2008 Jun;247(6):1029-35. doi: 10.1097/SLA.0b013e3181728a45.

PMID:
18520231
18.

Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.

Ozao-Choy J, Friedman ML, Kim AS, Wachsman A, Wolin EM, Yu R, Nissen NN, Colquhoun SD.

Pancreas. 2013 Mar;42(2):358-60. doi: 10.1097/MPA.0b013e31825f4087. No abstract available.

PMID:
23407486
19.

Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?

Pellerin O, Lin M, Bhagat N, Shao W, Geschwind JF.

Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):459-65.

20.

Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.

Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC.

J Vasc Interv Radiol. 2008 Jan;19(1):145-51. doi: 10.1016/j.jvir.2007.09.006.

PMID:
18192482

Supplemental Content

Support Center